Overall, both regimen were effectives with a normal IIEF EF domain score (≥26) achieved by 60.2% and 62.3% of patients, and a 72.6% and 74.4% mean per patient intercourse success rate.
Indeed, the number of clients per day, intercourse with clients during menstruation, STI-related treatment seeking behaviours, consistent condom use with clients, sweethearts or other non-paying sex partners and to what extent the FSWs had been forced or convinced not to use condoms by clients did not differ by duration of sex work.
Items about marriage and current relationship included age at marriage, decision about the future partner, forced marriage, meeting with spouse before marriage, like spouse before marriage, number of years married, satisfaction with marriage, hours spent with husband per day, frequency of sexual intercourse per week, husband allowance of intimacy, satisfaction after intimacy and marital rape.
Assuming one sex act per day that intercourse occurs, the probability of intercourse on any given day during the calendar year would equal 104/365, or 0.285.
For example, a patient who preoperatively reported her frequency of intercourse (per month) as 1 3 and postoperatively as 4 6 was identified as "better".
All enrolled women were at high risk of HIV acquisition, meaning that they reported three or more acts of intercourse per week and more than one sexual partner in the last three months.
The number of HIV infections averted (A) by the intervention was estimated according to Equation 1: where the intervention is assumed to increase the percentage of sexual encounters protected by condoms from ρb to ρi, ε is condom effectiveness per act of intercourse, R is the probability of acquiring HIV in the absence of the intervention, and N is the number of women in the intervention.
They came up with a set of numbers (for example, the increased likelihood of an individual transmitting HIV per act of sexual intercourse when he or she is infected with both the virus and the malarial parasite) that can be plugged into a mathematical model they have developed of how, based on other papers, they think the diseases interact.
Ongoing with the treatment the sexual activity further worsened with carvedilol (3.7 sexual intercourse episodes per month) while fully recovered and also improved with valsartan (10.2 sexual intercourse episodes per month).
During the first month of therapy, sexual activity (assessed as number of sexual intercourse episodes per month) declined with both drugs as compared with baseline, although the decrease was statistically significant in the carvedilol (from 8.2 to 4.4 sexual intercourse episodes, P <.01) but not in the valsartan-treated patients (from 8.3 to 6.6 sexual intercourse episodes, not significant).
